Sector News

Lilly appoints SVP of Corporate Affairs and Communications

May 10, 2017
Life sciences

Eli Lilly and Company announced today that Leigh Ann Pusey will be joining Lilly as senior vice president of corporate affairs and communications, effective June 12, 2017.

She will be a member of Lilly’s executive committee reporting directly to president and chief executive officer, David A. Ricks.

Pusey currently serves as president and CEO of the American Insurance Association (AIA), an insurance industry trade association representing more than 300 insurers that provide property and casualty insurance in the United States. She joined AIA in December 1996 and was promoted to president and CEO in February 2009. Pusey is consistently recognized by The Hill as one of the top lobbyists in Washington, D.C. and in 2012 she was named by National Journal as one of the 25 “Most Influential Women in Washington.”

“Leigh Ann brings a wealth of public affairs leadership experience to Lilly and at a particularly important time for our industry,” said Ricks. “Her ability to convene conversations and drive proactive policy solutions will be critical in our efforts to promote and sustain medical innovation so patients and the health care system benefit from a new era of medicine.”

Pusey serves in various capacities for a number of organizations, including as a member of the U.S. Chamber of Commerce’s Committee of 100, and board member of the Insurance Institute for Highway Safety. Prior to joining AIA, Pusey had been the deputy assistant to President George H.W. Bush for the White House Office of Public Liaison and deputy director of communications for the Republican National Committee. Pusey is a graduate of Samford University in Birmingham, Alabama. She currently resides in Alexandria, Virginia, with her husband and their two children.

Source: Eli Lilly and Company

comments closed

Related News

December 3, 2022

Sanofi moves into swanky new Paris HQ designed around hybrid work and sustainability

Life sciences

Monday, the French pharma giant officially moved into its new global home base in Paris, dubbed La Maison Sanofi. The 9,000-square-meter (about 96,875-square-foot) facility comprises two historic buildings and will host around 500 employees, the company explained in a release.

December 3, 2022

As CEO Schultz eyes retirement, Teva taps former Sandoz head Francis as its next leader

Life sciences

On the first day of the new year, former Sandoz chief Richard Francis will take the reins from Schultz, who is hanging up his CEO hat to retire on Dec. 31, Teva said Monday. The news comes a little more than two weeks after Teva publicly said it was looking for Schultz’s replacement.

December 3, 2022

General Electric sets healthcare division spinoff plans

Life sciences

General Electric Co. set the terms for the spinoff of its healthcare division, putting an initial value of roughly $31 billion on the soon-to-be-public company. The Boston conglomerate plans to split into three separate public companies by early 2024. Following the healthcare spinoff, it plans to separate its aerospace business from its power and renewable-energy units.